Parse Biosciences provides scalable, instrument-free single-cell sequencing solutions using its Evercode combinatorial barcoding technology. The company offers end-to-end workflows from sample preparation through library construction, sequencing, and immediate data insights via Trailmaker, enabling large-scale single-cell projects without specialized hardware. With products spanning whole transcriptome sequencing and immune profiling (TCR and BCR), Parse supports high-throughput analyses and flexible sample fixation to streamline experiments across researchers and institutions, including offerings like the GigaLab for very large cell cohorts. Headquartered in Seattle, Washington, the company emphasizes data-driven biology at unprecedented scale.
No recent deals for this company.